阿托伐他汀强化治疗急性缺血性脑卒中合并糖尿病的效果探讨

The Effect of Atorvastatin in the Intensive Treatment of Acute Ischemic Stroke with Diabetes

目的探讨阿托伐他汀强化治疗急性缺血性脑卒中合并糖尿病的临床效果。方法选取2018年1月—2019年1月急性缺血性脑卒中合并糖尿病患者70例,将其依据实际数字表法分成对照组(35例,对症治疗)与观察组(35例,阿托伐他汀强化治疗),对比两组血脂、血糖水平、神经功能缺损程度及治疗效果。结果观察组治疗总有效率较对照组显著升高(P<0.05)。观察组美国国立卫生研究院卒中量表(NIHSS)评分明显低于对照组(P<0.05)。观察组低密度脂蛋白胆固醇(LDL-C)、三酰甘油(TG)、总胆固醇(TC)明显低于对照组(P<0.05),而高密度脂蛋白胆固醇(HDL-C)水平高于对照组(P<0.05)。结论针对急性缺血性脑卒中合并糖尿病患者,采用阿托伐他汀强化治疗,效果理想。

Objective To explore the clinical effect of atorvastatin in the intensive treatment of acute ischemic stroke with diabetes.Methods From January 2018 to January 2019,70 patients with acute ischemic stroke and diabetes were selected and divided into control group(35 cases,symptomatic treatment)and observation group(35 cases,atovar based on the actual number table method Intensive statin treatment),compare the two groups of blood lipids,blood sugar levels,the degree of neurological deficits and treatment effects.Results The total effective rate of treatment in the observation group was significantly higher than that in the control group(P<0.05).The score of the National Institutes of Health Stroke Scale(NIHSS)in the observation group was significantly lower than that in the control group(P<0.05).The low-density lipoprotein cholesterol(LDL-C),triacylglycerol(TG)and total cholesterol(TC)of the observation group were significantly lower than those of the control group(P<0.05),while the high-density lipoprotein cholesterol(HDL-C)level was higher than control group(P<0.05).Conclusion For patients with acute ischemic stroke and diabetes,intensive treatment with atorvastatin is effective.